Apteka Studenckasp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2012-04-17
Share capital
531,100.00 PLN
Registered address
Langiewicza 16, 20-032 Lublin, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 92 days late).
- 202505/07/2026
- 202430/06/2025
- 202330/06/2024
- 202230/06/2023
- 202115/10/2022
- 202029/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 310.07kMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -17.64kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 327.64kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 66.67kMedianUSD 883.09kAverageUSD 31.39m
Industry
Authorized Representatives
Janusz Teodor Wargocki – Attorney-in-fact (sole)
Maria Wawruch – President of the Management Board
Manner of representation
In the case of a one-person management board, the company is represented independently by the President of the Management Board, whereas in the case of a multi-member management board, each member of the management board is authorised to make declarations and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Janusz Teodor Wargockiage 60 | 5,311 | $143,462.99 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $3,742.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $741$741 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 16, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Lublin | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $860$860 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Powerpharmasp. z o.o. | – | powerpharma.eu |
Change history
| Date | Event | |
|---|---|---|
| 2012-05-29 | Address change (Probostwo 17/25, 20-089, Lublin → Langiewicza 16, 20-032, Lublin) | |
| 2012-05-29 | Share capital increase (5,000.00 PLN → 531,100.00 PLN) | |
| 2012-04-17 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on April 17, 2012.
The headquarters is located at: Langiewicza 16, 20-032 Lublin.
The share capital of the company is PLN 531,100 (approx. $143,463).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $292,922, representing an increase of 0.6% compared to 2023.
Yes, the company recorded a net profit of $0 in 2024.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $227,639 in 2024, representing 75% of all operating expenses.
Last updated: 2026-07-05
